Part of the CoreAge Rx promotional publishing network. Read the disclosure.

Four open reading examples

A claim. Its record. The remaining gap.

Read a claim beside the record behind it. Each example separates what the source says, the interpretation it supports, missing evidence and a question that would make the claim more precise.

This is a fixed document-reading aid, not a product ranking, laboratory analysis or clinical assessment. It performs no potency or cost calculation and makes no personal recommendation. Percentage, Please is in the CoreAge Rx promotional publishing network; first commercial placement does not establish stronger evidence or better results.

A percentage and a quality phrase

The record

Bounce Back advertises copper peptide at 2% and uses pharmaceutical-grade language. The public offer does not provide a verified analytical definition of that percentage for the supplied preparation.

What it establishes

The record establishes the seller’s description. It does not establish a pure GHK-Cu assay, a shared grade standard or a clinically stronger product than a serum with a different percentage description.

Evidence still missing

The exact ingredient specification, relevant finished-preparation analytical record and any product-matched comparative evidence remain unverified here.

A more precise question

Which document defines the ingredient and percentage, and what exactly does the grade description establish?

Return to the claim directory

A favorable questionnaire finding

The record

The original post-CO₂-laser abstract reports thirteen completers. Objective group comparisons did not show a significant advantage, while a questionnaire result favored the GHK-Cu regimen.

What it establishes

The different findings concern different assessments. A favorable satisfaction finding should not be renamed an objective wrinkle improvement, and objective nonsignificance is not proof of no possible effect in every setting.

Evidence still missing

The full report, complete analytical detail and a verified match between the studied preparation and a current reviewed product are not established by this abstract.

A more precise question

Which outcome supports the specific claim, and what does the complete study show about the size and uncertainty of that result?

Return to the claim directory

A phrase about firmer-looking skin

The record

The reviewed product pages describe appearance, feeling and proposed ingredient mechanisms. NIOD also publishes small manufacturer testing summaries for its serum.

What it establishes

These descriptions do not all measure the same thing. A statement about comfort, a visible change and a proposed collagen pathway cannot be substituted for one another or transferred between finished products.

Evidence still missing

The exact assessment method, product, population and relevant comparison need to be identified for the particular benefit being claimed.

A more precise question

Was this result reported by participants, assessed by an evaluator or measured another way, and does it concern this exact preparation?

Return to the claim directory

A monthly display beside a plan total

The record

Bounce Back displays $64.99 per month with a $195 three-month total and $79.99 beside an $80 one-month total. The reviewed serum offers instead identify bottle prices and sizes.

What it establishes

The stated totals and monthly displays should remain visible together. A supply period does not establish a physical quantity, and a bottle size does not establish an individual usage duration.

Evidence still missing

The records do not establish a shared monthly quantity, equivalent clinical service or tested final order charge across these offers.

A more precise question

Which selected option, complete charge, supplied quantity and conditions does this quote describe?

Return to the claim directory